Decoy Therapeutics (DCOY) Asset Utilization Ratio (2016 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Asset Utilization Ratio of 0.01 for Q1 2022, down 89.45% year-over-year from 0.14 in Q1 2021, and down 65.39% quarter-over-quarter from 0.04 in Q4 2021.
Decoy Therapeutics (DCOY) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Asset Utilization Ratio for 7 consecutive years, with 0.01 the latest figure, recorded in Q1 2022.
- In Q1 2022, Asset Utilization Ratio fell 89.45% year-over-year to 0.01; the TTM figure through Mar 2022 stood at 0.01 (down 89.45% YoY), while the FY2021 annual figure was 0.06, down 79.24% from the prior year.
- Asset Utilization Ratio fell to 0.01 in Q1 2022 per DCOY's latest filing, from 0.04 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.29 in Q2 2019 and bottomed at 0.01 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.15 across 5 years, with a median of 0.14 in 2021.
- Annual changes were most pronounced in 2019 — Asset Utilization Ratio surged 450.02% — and 2022, when it sank 89.45%.
- Decoy Therapeutics' Asset Utilization Ratio stood at 0.1 in 2018, then jumped by 137.81% to 0.24 in 2019, then dropped by 10.78% to 0.22 in 2020, then plunged by 80.17% to 0.04 in 2021, then sank by 65.39% to 0.01 in 2022.
- Business Quant data shows DCOY's Asset Utilization Ratio at 0.01 in Q1 2022, 0.04 in Q4 2021, and 0.07 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 0.13 |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.14 |
| Dec 31, 2020 | 0.22 |
| Sep 30, 2020 | 0.23 |
| Jun 30, 2020 | 0.22 |
| Mar 31, 2020 | 0.23 |
| Dec 31, 2019 | 0.24 |
| Sep 30, 2019 | 0.24 |
| Jun 30, 2019 | 0.29 |
| Mar 31, 2019 | 0.21 |
| Dec 31, 2018 | 0.10 |
| Sep 30, 2018 | 0.08 |
| Jun 30, 2018 | 0.05 |
| Mar 31, 2018 | 0.04 |
| Dec 31, 2017 | 0.03 |
| Sep 30, 2017 | 0.03 |